Sangamo Therapeutics Reviews
Sangamo Therapeutics Reviews: What Is It Like to Work ... - Glassdoor
61 Sangamo Therapeutics reviews. A free inside look at company reviews and salaries posted anonymously by employees.
Working at Sangamo Therapeutics: 5 Reviews - Indeed
Employees are together as one and one unic family and, will help you get trained on their procedures and leads you towards a good path to success.
Working at Sangamo Therapeutics | Glassdoor
33% of job seekers rate their interview experience at Sangamo Therapeutics as positive. Candidates give an average difficulty score of 2.6 out of 5 (where 5 is ...
Working at Sangamo BioSciences: 6 Reviews - Indeed
It is very nice location, great work environment, fun to work in research team. There is always possibility to learn new things here.
Sangamo Therapeutics, Inc. Company Reviews
Really smart researchers, great research. People take their jobs seriously, but the culture is laid back. Good work life balance. Cons.
Working At Sangamo Therapeutics: Company Overview and Culture
Working at Sangamo Therapeutics · Patient-Centricity · Teamwork and Accountability · Innovation and Excellence · Urgency and Efficiency · Best-in-class healthcare ...
Critical Insights From Sangamo Therapeutics Analyst Ratings
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.75, a high estimate of $5.00, and a ...
We Think Shareholders May Want To Consider A Review Of ...
Over the last three years, Sangamo Therapeutics, Inc. has shrunk its earnings per share by 15% per year. Its revenue is down 92% over the ...
Sangamo Therapeutics, Inc. Careers - Blind
Really smart researchers, great research. People take their jobs seriously, but the culture is laid back. Good work life balance. Cons. Compensation could be a ...
Sangamo Therapeutics, Inc. | Pioneering Genetic Cures
Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene ...
Sangamo Therapeutics (SGMO) Customer reviews Statistics 2024
Sangamo Therapeutics underperforms its industry peers when it comes to Customer reviews, ranking dead last. Sign up and get more insights on Sangamo ...
SGMO | Sangamo Therapeutics Inc. Analyst Estimates & Ratings
Sangamo Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SGMO updated stock price target summary.
Sangamo Therapeutics Inc SGMO, Financial and Strategic SWOT ...
About the Report. Sangamo Therapeutics Inc (SGMO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's ...
Sangamo Therapeutics (NASDAQ:SGMO) Stock, Analyst Ratings ...
While ratings are subjective and will change, the latest Sangamo Therapeutics (SGMO) rating was a maintained with a price target of $3.00 to $9.00. The current ...
Sangamo Therapeutics, Inc. (SGMO) Analyst Ratings, Estimates ...
See Sangamo Therapeutics, Inc. (SGMO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Sangamo Therapeutics, Inc. Financial Overview, Employee ... - Apollo
No commitment. 5000 plus G2 reviews 5000+ G2 reviews. Company logo. Sangamo ... For Sangamo Therapeutics, science is a means to develop new medicines ...
Ratings Sangamo Therapeutics, Inc. - SGMO - MarketScreener
Summary: Sangamo Therapeutics, Inc. On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium ...
Sangamo Therapeutics, Inc. (SGMO) Analyst Ratings - Stock Analysis
Sangamo Therapeutics Analyst Ratings ; Total Analysts. 3 ; Consensus Rating. Buy ; Price Target. $6.00 ; Upside. +145.90% ...
Sangamo Therapeutics (SGMO) Stock Price, News & Analysis
The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings. Amount of Analyst Coverage. Sangamo Therapeutics ...
Sangamo Therapeutics - Facebook
Sangamo Therapeutics is dedicated to advancing genetic therapies in order to treat patients living with serious genetic diseases.